HCV genotypes and serum RNA levels in HCV-related cirrhosis with or without hepatocellular carcinoma (HCC).

被引：0
|
作者：
Adinolfi, LE [1 ]
Utili, R [1 ]
Andreana, A [1 ]
Ragone, E [1 ]
Cristiano, F [1 ]
Tonziello, A [1 ]
Mormone, G [1 ]
Gambardella, M [1 ]
Bellopede, P [1 ]
Rosario, P [1 ]
Marrone, A [1 ]
Ruggiero, G [1 ]
机构：
[1] UNIV NAPLES 2,FAC MED,INST MED THERAPY,NAPLES,ITALY
来源：
HEPATOLOGY | 1996年 / 24卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：107 / 107
页数：1
相关论文
共 50 条
  • [1] Familial clustering of HCV-related hepatocellular carcinoma (HCC)
    Pasta, L
    Bevacqua, EA
    Marrone, C
    d'Amico, M
    D'Amico, G
    Pagliaro, L
    GASTROENTEROLOGY, 2005, 128 (04) : A761 - A761
  • [2] Assessment of serum adiponectin in Egyptian patients with HCV-related cirrhosis and hepatocellular carcinoma
    Hamdy, K.
    Al Swaff, R.
    Hussein, H. A.
    Gamal, M.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2015, 38 (11) : 1225 - 1231
  • [3] Assessment of serum adiponectin in Egyptian patients with HCV-related cirrhosis and hepatocellular carcinoma
    K. Hamdy
    R. Al Swaff
    H. A. Hussein
    M. Gamal
    Journal of Endocrinological Investigation, 2015, 38 : 1225 - 1231
  • [4] Familial clustering of HCV-related liver cirrhosis and hepatocellular carcinoma
    Pasta, L
    Marrone, C
    D'amico, M
    Bevacqua, EA
    D'Amico, G
    Pagliaro, L
    DIGESTIVE AND LIVER DISEASE, 2005, 37 (09) : 716 - 717
  • [5] Serum VEGF as a Tumor Marker for Patients With HCV-Related Liver Cirrhosis and Hepatocellular Carcinoma
    Mukozu, Takanori
    Nagai, Hidenari
    Kobayashi, Koujirou
    Ogino, Yu
    Matui, Daigo
    Kanekawa, Takenori
    Kogame, Michio
    Takayama, Ryuji
    Kanayama, Masahiro
    Wakui, Noritaka
    Shinohara, Mie
    Shinohara, Masao
    Ishii, Koji
    Igarashi, Yoshinori
    Sumino, Yasukiyo
    GASTROENTEROLOGY, 2012, 142 (05) : S980 - S980
  • [6] Serum VEGF as a Tumor Marker in Patients with HCV-related Liver Cirrhosis and Hepatocellular Carcinoma
    Mukozu, Takanori
    Nagai, Hidenari
    Matsui, Daigo
    Kanekawa, Takenori
    Sumino, Yasukiyo
    ANTICANCER RESEARCH, 2013, 33 (03) : 1013 - 1021
  • [7] Increased serum reverse triiodothyronine levels at diagnosis of hepatocellular carcinoma in patients with compensated HCV-related liver cirrhosis
    Sorvillo, F
    Mazziotti, G
    Carbone, A
    Morisco, F
    Cioffi, M
    Rotondi, M
    Stornaiuolo, G
    Amato, G
    Gaeta, GB
    Caporaso, N
    Carella, C
    CLINICAL ENDOCRINOLOGY, 2003, 58 (02) : 207 - 212
  • [8] EGF rs4444903 polymorphism is associated with risk of HCV-related cirrhosis and HBV/HCV-related hepatocellular carcinoma
    Wang, Jia
    Zhong, Yanlin
    Meng, Guixia
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2021, 26 (11) : 2053 - 2064
  • [9] Liver cell proliferation by PCNA and HCV recurrence in patients transplanted for HCV-related cirrhosis with or without hepatocellular carcinoma.
    Donato, MF
    Agnelli, F
    Arosio, E
    Monti, V
    Balestrieri, MR
    Rizzi, P
    Colombo, M
    HEPATOLOGY, 2001, 34 (04) : 408A - 408A
  • [10] EGF rs4444903 polymorphism is associated with risk of HCV-related cirrhosis and HBV/HCV-related hepatocellular carcinoma
    Jia Wang
    Yanlin Zhong
    Guixia Meng
    International Journal of Clinical Oncology, 2021, 26 : 2053 - 2064
12345